Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy.

TheMotleyFool

0 0

Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy.: https://g.foolcdn.com/editorial/images/767017/person-taking-medication-after-virtual-appointment.jpg

Shares of direct-to-consumer telehealth business Hims & Hers Health (NYSE: HIMS) are up 30% since the company reported its Q4 earnings. The little-known $2 billion company is grabbing investors' attention with eye-popping growth and rapidly improving financials.

It often feels like you've missed the boat when you sit there reading about another stock that got hot before you realized what was happening, but you haven't -- Hims & Hers is still a magnificent buy for long-term investors today.

I'll detail why the company's performance is no fluke, and why investors can confidently buy this potential future multibagger.

Source Fool.com

Like: 0

HIMS

Share